Cleveland-Cliffs, Inc. Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell

39

CLF
Cleveland-Cliffs, Inc.

Last Price:

$12.71

Seasonality Move:

6.63%

Buy

77

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:

$113.50

Seasonality Move:

-9.01%

Sell

39

Cleveland-Cliffs, Inc. (CLF) is a Sell

Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?

The current Cleveland-Cliffs, Inc. [CLF] share price is $12.71. The Score for CLF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

77

Rhythm Pharmaceuticals, Inc. (RYTM) is a Buy

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $113.56. The Score for RYTM is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CLF Stock Price Chart

What is Cleveland-Cliffs, Inc.'s stock price today?

The Cleveland-Cliffs, Inc. share price today is $12.71

The current trend is moderately bullish and CLF is experiencing selling pressure, which indicates risk of future bearish movement.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

The Rhythm Pharmaceuticals, Inc. share price today is $113.56

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

CLF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.27	Buy
Relative Strength Index (14 RSI):	54.21	Buy
Chaikin Money Flow:	-12267118	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(10.85 - 12.85)	Buy
Bollinger Bands (100):	(10.36 - 13.04)	Buy

RYTM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.67	Buy
Relative Strength Index (14 RSI):	59.45	Buy
Chaikin Money Flow:	-357754	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(98.81 - 108.61)	Buy
Bollinger Bands (100):	(93.91 - 107.83)	Buy

CLF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	12.71	Buy
20-day SMA:	12.19	Buy
50-day SMA:	12.46	Buy
200-day SMA:	9.96	Buy
8-day EMA:	12.71	Sell
20-day EMA:	12.39	Buy
50-day EMA:	12.11	Buy
200-day EMA:	11.16	Buy

RYTM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	107.1	Buy
20-day SMA:	105.06	Buy
50-day SMA:	105.14	Buy
200-day SMA:	81.74	Buy
8-day EMA:	108.55	Buy
20-day EMA:	106.16	Buy
50-day EMA:	103.93	Buy
200-day EMA:	86.65	Buy

Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.55 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $2.71 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.02 per share, and an increase next year of $0.56 per share.

Cleveland-Cliffs, Inc. Technical Analysis

	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12
	Dec
	01	02	03	04	05	08	09	10	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

	Dec 1	Dec 2	Dec 3	Dec 4	Dec 5	Dec 8	Dec 9	Dec 10	Dec 11	Dec 12
	Dec
	01	02	03	04	05	08	09	10	11	12
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):